London biotech raises Future Fund bridge to series A
We acted for a VC-backed London-based biotech company on its funding round using convertible debt to bridge to a future series A round. The management team took advantage of the UK government’s Future Fund, operated by the British Business Bank, to match funding provided by multiple UK and US VCs and angel investors.
Deal/project: Future Fund bridge round
Date closed: September 2020